Cytodyn Inc (CYDY)

$0.30 +0.00 (1.57%)
Market Cap 378.77M
Revenue (ttm) 0.00
Net Income (ttm) 3.75M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,418,700
Avg Vol 1,860,794
Day's Range N/A - N/A
Shares Out 1.26B
Stochastic %K 81%
Beta 1.33
Analysts Strong Buy
Price Target $4.00

Company Profile

CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. It is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. The company's leronlimab is currently under phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer. The co...

Industry: Biotechnology
Sector: Healthcare
Phone: 360 980 8524
Fax: 360 799 5954
Address:
1111 Main Street, Suite 660, Vancouver, United States
Four_Horsemen4Life
Four_Horsemen4Life Nov. 23 at 1:23 AM
$CYDY What does the fox say?
1 · Reply
OB1_
OB1_ Nov. 23 at 1:18 AM
$CYDY https://www.linkedin.com/posts/petetanhc_when-jeff-bezos-ex-wife-mackenzie-scott-activity-7393624780433911808-JxKF?utm_medium=ios_app&rcm=ACoAAFPQSCoBAk6vc4JwrmdJgkreIZfkw2AK9oc&utm_source=social_share_send&utm_campaign=copy_link
1 · Reply
Twinter11
Twinter11 Nov. 23 at 12:38 AM
$CYDY San Antonio BC Dec 12th Is the poster titled After *maybe* Leronlimab induced PD-L1? I dont think so. "Prolonged survival following PD-L1/PD-1 immune checkpoint inhibitor therapy after leronlimab induced PD-L1 upregulation on cancer-associated macrophage-like cells and circulating tumor cells in patients with metastatic or locally advanced triple-negative breast cancer Milana V Dolezal, Stanford University School of Medicine, Stanford, CA"
2 · Reply
Sbowers59
Sbowers59 Nov. 22 at 11:29 PM
$CYDY easy decision
0 · Reply
HouseintheCountry
HouseintheCountry Nov. 22 at 10:33 PM
$CYDY enough clutter
0 · Reply
ContinentalExpat
ContinentalExpat Nov. 22 at 9:57 PM
$CYDY Mazzy you must feel great being the one to warn us all about the evils of a 30 cent biopharma company. Of all the evils in the world, you've picked an unknown company with an unknown monoclonal antibody to make your stand. Superman (I assume) Can you enlighten us on any other companies to be aware of? I did say I’d buy you a drink in Vegas. Just curious, ”Soy Milk”?
3 · Reply
PhyscoChicken
PhyscoChicken Nov. 22 at 9:34 PM
$CYDY Hopefully we settle back up to $.37 . Looking to add another 60,000 shares. Expect this to happen next week.
3 · Reply
Four_Horsemen4Life
Four_Horsemen4Life Nov. 22 at 9:00 PM
$CYDY Hopefully we settle back down around .20 on 12/31. Looking to add another 60,000 shares before the move up past .50 in 2026….
1 · Reply
Four_Horsemen4Life
Four_Horsemen4Life Nov. 22 at 8:32 PM
$CYDY For Life!!!
0 · Reply
Four_Horsemen4Life
Four_Horsemen4Life Nov. 22 at 6:17 PM
$CYDY This stock no scam Paosag
0 · Reply
Latest News on CYDY
No data available.
Four_Horsemen4Life
Four_Horsemen4Life Nov. 23 at 1:23 AM
$CYDY What does the fox say?
1 · Reply
OB1_
OB1_ Nov. 23 at 1:18 AM
$CYDY https://www.linkedin.com/posts/petetanhc_when-jeff-bezos-ex-wife-mackenzie-scott-activity-7393624780433911808-JxKF?utm_medium=ios_app&rcm=ACoAAFPQSCoBAk6vc4JwrmdJgkreIZfkw2AK9oc&utm_source=social_share_send&utm_campaign=copy_link
1 · Reply
Twinter11
Twinter11 Nov. 23 at 12:38 AM
$CYDY San Antonio BC Dec 12th Is the poster titled After *maybe* Leronlimab induced PD-L1? I dont think so. "Prolonged survival following PD-L1/PD-1 immune checkpoint inhibitor therapy after leronlimab induced PD-L1 upregulation on cancer-associated macrophage-like cells and circulating tumor cells in patients with metastatic or locally advanced triple-negative breast cancer Milana V Dolezal, Stanford University School of Medicine, Stanford, CA"
2 · Reply
Sbowers59
Sbowers59 Nov. 22 at 11:29 PM
$CYDY easy decision
0 · Reply
HouseintheCountry
HouseintheCountry Nov. 22 at 10:33 PM
$CYDY enough clutter
0 · Reply
ContinentalExpat
ContinentalExpat Nov. 22 at 9:57 PM
$CYDY Mazzy you must feel great being the one to warn us all about the evils of a 30 cent biopharma company. Of all the evils in the world, you've picked an unknown company with an unknown monoclonal antibody to make your stand. Superman (I assume) Can you enlighten us on any other companies to be aware of? I did say I’d buy you a drink in Vegas. Just curious, ”Soy Milk”?
3 · Reply
PhyscoChicken
PhyscoChicken Nov. 22 at 9:34 PM
$CYDY Hopefully we settle back up to $.37 . Looking to add another 60,000 shares. Expect this to happen next week.
3 · Reply
Four_Horsemen4Life
Four_Horsemen4Life Nov. 22 at 9:00 PM
$CYDY Hopefully we settle back down around .20 on 12/31. Looking to add another 60,000 shares before the move up past .50 in 2026….
1 · Reply
Four_Horsemen4Life
Four_Horsemen4Life Nov. 22 at 8:32 PM
$CYDY For Life!!!
0 · Reply
Four_Horsemen4Life
Four_Horsemen4Life Nov. 22 at 6:17 PM
$CYDY This stock no scam Paosag
0 · Reply
Four_Horsemen4Life
Four_Horsemen4Life Nov. 22 at 6:16 PM
$CYDY Some people can’t handle being patient and think anyone not cheerleading is a short.
2 · Reply
Four_Horsemen4Life
Four_Horsemen4Life Nov. 22 at 5:44 PM
$CYDY Not expecting another PR in 2025; temper expectations…
1 · Reply
BioSniper101
BioSniper101 Nov. 22 at 5:39 PM
$CYDY CYDY has enough “shelved” shares for a partner. 1) The realistic partner-size range is 10M to 100M shares. 2) The maximum theoretical allocation is 167M shares (9.5% of authorized). 3) Anything larger than 9.5% requires shareholder approval to increase authorized shares again.
0 · Reply
GOCYDY
GOCYDY Nov. 22 at 5:36 PM
$CYDY More is Better ‼️💯🙏🏼 Interviews, conferences, articles, publications, and now analyst! Word is getting out and everything I see is positive  https://www.reddit.com/r/Livimmune/s/g2i1q23Zxg
2 · Reply
Four_Horsemen4Life
Four_Horsemen4Life Nov. 22 at 2:46 PM
$CYDY @Cytomight We come in peace. There are rumors that you are considering our offer to merge forces. It would send shockwaves throughout the CYDY community. @mgk would write a masterpiece entitled ”Turning Cold Shorts Hot.”
1 · Reply
Trakal1
Trakal1 Nov. 22 at 2:33 PM
$CYDY Now that the shareholder vote is out of the way, news could start coming any day next week thru January. Keep the faith, onward and upward we go from here.
3 · Reply
Four_Horsemen4Life
Four_Horsemen4Life Nov. 22 at 2:01 PM
$CYDY @Cytomight We come in peace. There are rumors that you are considering our offer to merge forces. It would send shockwaves throughout the CYDY community. @mgk would write a masterpiece entitled ”Turning Cold Shorts Hot.”
1 · Reply
NorthcoastKI
NorthcoastKI Nov. 22 at 1:41 PM
$CYDY If you zoom out over the past yr you will notice we get a spike every 3 or 4 months. we are due to one next week or the following. Hopefully this will finally turn the worm for us
1 · Reply
phoenixblaze
phoenixblaze Nov. 22 at 1:12 PM
$CYDY https://www.instagram.com/reel/DRR_eHkCLVk/?igsh=dHZpZnB0ZXFsM3dn
0 · Reply
Cytomight
Cytomight Nov. 22 at 12:40 PM
$CYDY THEY NEED TO COVER IN THE .20’s and LOSING IT‼️😆
1 · Reply
Four_Horsemen4Life
Four_Horsemen4Life Nov. 22 at 11:17 AM
$CYDY Cytodyn is meeting with the FDA on 12/3…
2 · Reply
Jon_Reddick
Jon_Reddick Nov. 22 at 9:28 AM
$CYDY @paosag this stock NO scam
0 · Reply